These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 10649594)
1. In vitro percutaneous absorption of fusidic acid and betamethasone 17-valerate across canine skin. Degim IT; Hadgraft J; Houghton E; Teale P J Small Anim Pract; 1999 Nov; 40(11):515-8. PubMed ID: 10649594 [TBL] [Abstract][Full Text] [Related]
2. Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy. Franz TJ; Parsell DA; Halualani RM; Hannigan JF; Kalbach JP; Harkonen WS Int J Dermatol; 1999 Aug; 38(8):628-32. PubMed ID: 10487457 [TBL] [Abstract][Full Text] [Related]
3. Feasibility of measuring lipophilic or protein-bound drugs in the dermis by in vivo microdialysis after topical or systemic drug administration. Benfeldt E; Groth L Acta Derm Venereol; 1998 Jul; 78(4):274-8. PubMed ID: 9689295 [TBL] [Abstract][Full Text] [Related]
4. Topical fusidic acid/betamethasone-containing gel compared to systemic therapy in the treatment of canine acute moist dermatitis. Cobb MA; Edwards HJ; Jagger TD; Marshall J; Bowker KE Vet J; 2005 Mar; 169(2):276-80. PubMed ID: 15727921 [TBL] [Abstract][Full Text] [Related]
5. Opportunities for topical antimicrobial therapy: permeation of canine skin by fusidic acid. Frosini SM; Bond R; Loeffler A; Larner J BMC Vet Res; 2017 Nov; 13(1):345. PubMed ID: 29162115 [TBL] [Abstract][Full Text] [Related]
7. Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development. Nagaich U; Gulati N Curr Drug Deliv; 2018; 15(5):641-651. PubMed ID: 28925874 [TBL] [Abstract][Full Text] [Related]
8. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate. Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous diffusion and metabolism of betamethasone 17-valerate in the living skin equivalent. Kubota K; Ademola J; Maibach HI J Pharm Sci; 1995 Dec; 84(12):1478-81. PubMed ID: 8748331 [TBL] [Abstract][Full Text] [Related]
10. Impact of synthetic canine cerumen on in vitro penetration of auricular skin of dogs by florfenicol, terbinafine, and betamethasone acetate. Ehling S; Baynes RE; Bäumer W Am J Vet Res; 2018 Mar; 79(3):333-341. PubMed ID: 29466046 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous metabolism and penetration of methoxypsoralen, betamethasone 17-valerate, retinoic acid, nitroglycerin and theophylline. Ademola JI; Maibach HI Curr Probl Dermatol; 1995; 22():201-13. PubMed ID: 7587326 [No Abstract] [Full Text] [Related]
12. Metabolism of topical drugs within the skin, in particular glucocorticoids. Kubota K; Ademola J; Maibach HI Curr Probl Dermatol; 1993; 21():61-6. PubMed ID: 8299377 [No Abstract] [Full Text] [Related]
13. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles. Zhang J; Smith E J Pharm Sci; 2011 Mar; 100(3):896-903. PubMed ID: 20839362 [TBL] [Abstract][Full Text] [Related]
14. Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin. Gysler A; Kleuser B; Sippl W; Lange K; Korting HC; Höltje HD; Korting HC Pharm Res; 1999 Sep; 16(9):1386-91. PubMed ID: 10496654 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a novel stability-indicating HPLC method for the simultaneous assay of betamethasone-17-valerate, fusidic acid, potassium sorbate, methylparaben and propylparaben in a topical cream preparation. Byrne J; Velasco-Torrijos T; Reinhardt R J Pharm Biomed Anal; 2014 Aug; 96():111-7. PubMed ID: 24731970 [TBL] [Abstract][Full Text] [Related]
16. Spectrophotometric methods for simultaneous determination of betamethasone valerate and fusidic acid in their binary mixture. Lotfy HM; Salem H; Abdelkawy M; Samir A Spectrochim Acta A Mol Biomol Spectrosc; 2015 Apr; 140():294-304. PubMed ID: 25615682 [TBL] [Abstract][Full Text] [Related]
17. Formulation factors affecting the isomerization rate of betamethasone-17-valerate in a developmental hydrophilic cream - a HPLC and microscopy based stability study. Byrne J; Wyraz A; Velasco-Torrijos T; Reinhardt R Pharm Dev Technol; 2017 Jun; 22(4):537-544. PubMed ID: 26895450 [TBL] [Abstract][Full Text] [Related]
18. Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams. Shah VP; Elkins J; Skelly JP J Pharm Sci; 1992 Jan; 81(1):104-6. PubMed ID: 1619561 [TBL] [Abstract][Full Text] [Related]
19. Penetration and permeation into human skin of fusidic acid in different galenical formulation. Stüttgen G; Bauer E Arzneimittelforschung; 1988 May; 38(5):730-5. PubMed ID: 3415719 [TBL] [Abstract][Full Text] [Related]
20. Palm Olein Emulsion: a Novel Vehicle for Topical Drug Delivery of Betamethasone 17-Valerate. Ahmad K; Win T; Jaffri JM; Edueng K; Taher M AAPS PharmSciTech; 2018 Jan; 19(1):371-383. PubMed ID: 28744617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]